drugset / Trial / NCT03414112

The Impact of Oxytocin on the Neurobiology of Anorexia Nervosa

NCT03414112

RandomizedParallel-groupTriple-blindOther

Summary

This study will use a randomized, controlled, double-blind design involving the administration of intranasal oxytocin (INOT) or placebo to adults with anorexia nervosa, restricting subtype and age-matched controls prior to neuroimaging to assess the impact on frontolimbic brain activity in response to socioemotional stimuli as well as eating behavior in a test meal paradigm.

Timeline

Start
2018-09-25
Primary completion
2021-04-30
Completion
2021-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide Intranasal

Indications